As of 2026-08-25, Oragenics Inc. (OGEN) has a 3-month relative strength percentile of 28 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 0.40×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
OGEN is in a stage 4 downtrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.8% / -27.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OGEN Jan avg: -15.86% median: -5.83% win: 50% σ: 30.72% n: 4 2022-04-12 → 2026-07-31 | OGEN Feb avg: -18.59% median: -18.23% win: 0% σ: 18.29% n: 4 2022-04-12 → 2026-07-31 | OGEN Mar avg: -22.18% median: -28.04% win: 25% σ: 15.46% n: 4 2022-04-12 → 2026-07-31 | OGEN Apr avg: -11.49% median: -11.52% win: 20% σ: 12.28% n: 5 2022-04-12 → 2026-07-31 | OGEN May avg: 13.31% median: 1.95% win: 60% σ: 48.67% n: 5 2022-04-12 → 2026-07-31 | OGEN Jun avg: -5.78% median: 6.11% win: 60% σ: 24.53% n: 5 2022-04-12 → 2026-07-31 | OGEN Jul avg: -12.05% median: 0.00% win: 60% σ: 32.73% n: 5 2022-04-12 → 2026-07-31 | OGEN Aug avg: -4.04% median: -10.01% win: 25% σ: 17.96% n: 4 2022-04-12 → 2026-07-31 (current) | OGEN Sep avg: -21.90% median: -22.41% win: 25% σ: 39.88% n: 4 2022-04-12 → 2026-07-31 | OGEN Oct avg: -2.14% median: -5.89% win: 25% σ: 17.66% n: 4 2022-04-12 → 2026-07-31 | OGEN Nov avg: -8.91% median: -5.06% win: 25% σ: 14.24% n: 4 2022-04-12 → 2026-07-31 | OGEN Dec avg: 4.18% median: 3.08% win: 50% σ: 43.70% n: 4 2022-04-12 → 2026-07-31 |